mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.1 |